Pfizer publishes clinical trial diversity data from past decade, showing there's much work to be done

The pandemic turned a harsh spotlight on a historic lack of diversity in the biopharma industry. Now, in an effort to foster transparency, Pfizer has published diversity data from its clinical trials going back 10 years, showing there’s much work to be done.